Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04836481 · ClinicalTrials.gov registry record
A Pharmacokinetic Analysis of Levetiracetam Prophylaxis in Critically Ill Patients With Severe Traumatic Brain Injury
A clinical trial, sponsored by University of Cincinnati.
- Completed
- Registry status
- 10
- Enrollment target
NCT04836481 is a clinical trial that has completed, run by University of Cincinnati. The registered enrollment target is 10 participants.
The verdict
NCT04836481 has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
This study aims is to describe the pharmacokinetic properties of levetiracetam through measurement of serum concentrations in critically ill, severe traumatic brain injury patients.
Interventions
- OTHER Serum Sample Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2023-10-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04836481
The ClinicalTrials.gov registry entry for NCT04836481 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Serum Sample Collection is the first listed.
NCT04836481 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04836481 about?
NCT04836481 is a clinical study titled "A Pharmacokinetic Analysis of Levetiracetam Prophylaxis in Critically Ill Patients With Severe Traumatic Brain Injury". This study aims is to describe the pharmacokinetic properties of levetiracetam through measurement of serum concentrations in critically ill, severe traumatic brain injury patients.
What is the current status of trial NCT04836481?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2021-01-01. Estimated completion is 2023-10-01.
What interventions are being tested in trial NCT04836481?
The interventions under investigation include: Serum Sample Collection (OTHER).
Who is sponsoring clinical trial NCT04836481?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.